SARS-CoV-2 Vaccination in Children and Adolescents with and Without Type 1 Diabetes Mellitus

Overview

Journal Endocrine

Specialty Endocrinology

Date 2023 Aug 16

PMID 37587391

Authors

Kyriaki Karavanaki

Spyridon Karanasios

Alexandra Soldatou

Maria Tsolia

Affiliations

Soon will be listed here.

Abstract

Adults with Diabetes Mellitus (DM) have increased risk of severe clinical presentation during COVID-19 infection, while children and adolescents with type 1 diabetes (T1D) have the same mild clinical course as their healthy peers, especially those with optimal glycemic control. The present review focuses on the necessity of COVID-19 vaccination among children and adolescents with T1D, and also in their non-diabetic peers. The efficacy and safety of COVID-19 vaccines are also discussed, as well as their various side-effects, ranging from common mild to very rare and serious ones. Furthermore, the results of COVID-19 vaccination of adolescents with and without T1D are reported, as well as the efficacy and concerns about childhood vaccination. It is concluded that patients with DM of all age groups should maintain optimal diabetic control in order to avoid glycemic deterioration during COVID-19 infection. Furthermore, despite the very rare and serious complications of COVID-19 vaccines, vaccination against COVID-19 is recommended for children and adolescents with T1D to prevent glycemic deterioration and rare but serious complications of COVID-19 infection.

References

Podhorecka M, Pyszora A, Wozniewicz A, Husejko J, Kedziora-Kornatowska K . Health and Protective Measures for Seniors during the COVID-19 Pandemic in the Opinion of Polish Society. Int J Environ Res Public Health. 2021; 18(17). PMC: 8430700. DOI: 10.3390/ijerph18179230. View

Pal R, Bhadada S, Misra A . COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021; 15(2):505-508. PMC: 7904463. DOI: 10.1016/j.dsx.2021.02.026. View

Kusuma Boddu S, Aurangabadkar G, Kuchay M . New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2021; 14(6):2211-2217. PMC: 7669477. DOI: 10.1016/j.dsx.2020.11.012. View

Brufsky A . Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J Med Virol. 2020; 92(7):770-775. PMC: 7262330. DOI: 10.1002/jmv.25887. View

Sen S, Chakraborty R, Kalita P, Pathak M . Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases. 2021; 9(28):8327-8339. PMC: 8554438. DOI: 10.12998/wjcc.v9.i28.8327. View

Wu C, Lidsky P, Xiao Y, Lee I, Cheng R, Nakayama T . SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021; 33(8):1565-1576.e5. PMC: 8130512. DOI: 10.1016/j.cmet.2021.05.013. View

Kazakou P, Lambadiari V, Ikonomidis I, Kountouri A, Panagopoulos G, Athanasopoulos S . Diabetes and COVID-19; A Bidirectional Interplay. Front Endocrinol (Lausanne). 2022; 13:780663. PMC: 8891603. DOI: 10.3389/fendo.2022.780663. View

Palermo N, Sadhu A, McDonnell M . Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations. J Clin Endocrinol Metab. 2020; 105(8). PMC: 7337869. DOI: 10.1210/clinem/dgaa360. View

Cardona-Hernandez R, Cherubini V, Iafusco D, Schiaffini R, Luo X, Maahs D . Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr Diabetes. 2020; 22(2):202-206. PMC: 7753354. DOI: 10.1111/pedi.13158. View

10.

Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

11.

Siebach M, Piedimonte G, Ley S . COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol. 2021; 56(6):1342-1356. PMC: 8137603. DOI: 10.1002/ppul.25344. View

12.

Sinaei R, Pezeshki S, Parvaresh S, Sinaei R . Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2020; 17(1):10-20. PMC: 7518650. DOI: 10.1007/s12519-020-00392-y. View

13.

Stein M, Ashkenazi-Hoffnung L, Greenberg D, Dalal I, Livni G, Chapnick G . The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines (Basel). 2022; 10(1). PMC: 8781684. DOI: 10.3390/vaccines10010081. View

14.

Kildegaard H, Lund L, Hojlund M, Stensballe L, Pottegard A . Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study. BMJ. 2022; 377:e068898. PMC: 8995669. DOI: 10.1136/bmj-2021-068898. View

15.

Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A . Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?. Diabetes Care. 2020; 43(11):2870-2872. DOI: 10.2337/dc20-1321. View

16.

Pitocco D, Viti L, Tartaglione L, Di Leo M, Rizzo G, Manto A . Diabetes and severity of COVID-19: What is the link?. Med Hypotheses. 2020; 143:109923. PMC: 7260494. DOI: 10.1016/j.mehy.2020.109923. View

17.

Alonso G, Ebekozien O, Gallagher M, Rompicherla S, Lyons S, Choudhary A . Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J Diabetes. 2021; 13(8):681-687. PMC: 8251108. DOI: 10.1111/1753-0407.13184. View

18.

Basatemur E, Jones A, Peters M, Ramnarayan P . Paediatric critical care referrals of children with diabetic ketoacidosis during the COVID-19 pandemic. Arch Dis Child. 2020; 106(4):e21. DOI: 10.1136/archdischild-2020-320471. View

19.

Al-Abdulrazzaq D, Alkandari A, Alhusaini F, Alenazi N, Gujral U, Narayan K . Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic. Diabetes Metab Res Rev. 2021; 38(3):e3506. PMC: 8646429. DOI: 10.1002/dmrr.3506. View

20.

Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay J, Brockman N . Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes. 2021; 22(4):552-557. PMC: 8251027. DOI: 10.1111/pedi.13205. View